| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.613 | 46.125 | 38.964 | 48.619 | 51.075 | 34.407 | 38.378 | 32.067 | 28.907 | 33.613 |
| Total Income - EUR | 50.613 | 46.125 | 38.964 | 70.259 | 68.671 | 38.353 | 38.378 | 32.067 | 37.398 | 33.613 |
| Total Expenses - EUR | 40.622 | 66.158 | 51.451 | 69.515 | 67.789 | 37.999 | 37.745 | 31.602 | 36.644 | 30.492 |
| Gross Profit/Loss - EUR | 9.991 | -20.033 | -12.488 | 744 | 881 | 354 | 633 | 465 | 754 | 3.121 |
| Net Profit/Loss - EUR | 8.473 | -20.494 | -13.831 | 42 | 195 | 108 | 333 | 144 | 380 | 2.496 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Datix Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.796 | 51.817 | 102.135 | 90.740 | 69.519 | 55.829 | 46.514 | 39.461 | 30.960 | 24.178 |
| Current Assets | 14.258 | 2.415 | 4.511 | 2.326 | 1.931 | 2.092 | 39 | 2.323 | 1.739 | 10.763 |
| Inventories | 2.182 | 2.160 | 2.220 | 2.284 | 1.564 | 1.534 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 195 | 2.034 | 0 | 148 | 416 | 0 | 0 | 0 | 2 |
| Cash | 12.076 | 60 | 257 | 42 | 219 | 143 | 39 | 2.323 | 1.739 | 10.761 |
| Shareholders Funds | 29.786 | 602 | -13.239 | -12.954 | -12.508 | -12.163 | -11.561 | -11.452 | -11.037 | -8.480 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.267 | 53.630 | 119.884 | 106.020 | 83.958 | 70.084 | 58.113 | 53.236 | 43.737 | 43.421 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Datix Med Srl